Replimune: FDA Notified the Co to Expect Advisory Committee Meeting in Late July >REPL
Dow Jones Newswires
Replimune: FDA Notified the Co to Expect Advisory Committee Meeting in Late July >REPL
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:REPL
- Language
- English